FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147963907> ?p ?o ?g. }

• W3147963907 abstract "Clinical characteristics Beta-propeller protein-associated neurodegeneration (BPAN) is typically characterized by early-onset seizures, infantile-onset developmental delay, intellectual disability, absent to limited expressive language, motor dysfunction (ataxia), and abnormal behaviors often similar to autism spectrum disorder. Seizure types including generalized (absence, tonic, atonic, tonic-clonic and myoclonic), focal with impaired consciousness, and epileptic spasms, as well as epileptic syndromes (West syndrome and Lennox-Gastaut syndrome) can be seen. With age seizures tend to resolve or become less prominent, whereas cognitive decline and movement disorders (progressive parkinsonism and dystonia) emerge as characteristic findings. Diagnosis/testing The diagnosis of BPAN is established by identifying on molecular genetic testing: In females. A heterozygous WDR45 germline pathogenic variant; In males. Either a hemizygous WDR45 pathogenic variant or partial deletion of WDR45. Somatic mosaicism has been reported in rare females (and possibly in 1 male). Management Treatment of manifestations: Seizure management, tailored to the individual, may include antiepileptic drugs (AEDs), ketogenic diet, and/or vagus nerve stimulation. Developmental delays and intellectual disability are managed in infancy and early childhood with early intervention programs and in school-age children with individual education programs. Consultation with a developmental pediatrician to ensure appropriate services is recommended. Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Consider alternative means of communication, such as an Augmentative and Alternative Communication (AAC) program, for individuals who have expressive language difficulties. Motor dysfunction in childhood is managed with physical therapy to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation). Occupational therapy may aid in writing, feeding, grooming, and dressing. For those with feeding difficulties, feeding therapy may be considered. For individuals with social/behavioral difficulties, consider applied behavior analysis (ABA) therapy, medical management strategies in conjunction with a developmental specialist, and pediatric psychiatry consultation to address aggressive or destructive behaviors. In adolescents/adults with parkinsonism, dystonia, and spasticity, the usual pharmacologic agents can be considered with the caveat that these therapies could exacerbate the cognitive deficits that also occur in this age group. Children with abnormal behaviors may qualify for and benefit from interventions used in treatment of autism spectrum disorder. Surveillance: Routine follow up by a neurologist for medication management and interval assessment of ambulation, seizure activity, speech, and evidence of swallowing dysfunction. For those receiving dopaminergic drugs (for parkinsonism), monitor for adverse neuropsychiatric effects and disabling motor fluctuations and dyskinesias. Pregnancy management: Use of AEDs during pregnancy for women with a seizure disorder is generally recommended, despite an increased risk for adverse fetal outcome associated with some AEDs. Discussion of the risks and benefits of using a given antiepileptic medication during pregnancy ideally should take place prior to conception. Transitioning to a lower-risk medication may be possible. Genetic counseling BPAN is inherited in an X-linked manner; to date, most affected individuals have been female, and the vast majority are simplex cases (i.e., a single occurrence in a family) resulting from a de novo WDR45 pathogenic variant. The exceptions include two familial cases, one with presumed maternal germline mosaicism and one with transmission of a WDR45 pathogenic variant by a phenotypically normal mother who demonstrated significantly skewed X-chromosome inactivation. Females with the typical BPAN phenotype do not reproduce. In rare instances, a female who is mildly affected may reproduce. Affected males do not reproduce. Once the WDR45 pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing for BPAN are possible." @default.
• W3147963907 created "2021-04-13" @default.
• W3147963907 creator A5011228927 @default.
• W3147963907 creator A5017916851 @default.
• W3147963907 creator A5051511541 @default.
• W3147963907 creator A5065636582 @default.
• W3147963907 creator A5066801518 @default.
• W3147963907 date "2017-02-16" @default.
• W3147963907 modified "2023-09-24" @default.
• W3147963907 title "Beta-Propeller Protein-Associated Neurodegeneration" @default.
• W3147963907 cites W1522857888 @default.
• W3147963907 cites W1533548496 @default.
• W3147963907 cites W171019578 @default.
• W3147963907 cites W1979081257 @default.
• W3147963907 cites W2013834016 @default.
• W3147963907 cites W2029644308 @default.
• W3147963907 cites W2031780560 @default.
• W3147963907 cites W2032601500 @default.
• W3147963907 cites W2043291430 @default.
• W3147963907 cites W2045373134 @default.
• W3147963907 cites W2055555768 @default.
• W3147963907 cites W2067452302 @default.
• W3147963907 cites W2073428701 @default.
• W3147963907 cites W2076781430 @default.
• W3147963907 cites W2085172895 @default.
• W3147963907 cites W2086280394 @default.
• W3147963907 cites W2108205380 @default.
• W3147963907 cites W2115972690 @default.
• W3147963907 cites W2116232642 @default.
• W3147963907 cites W2122507858 @default.
• W3147963907 cites W2123625952 @default.
• W3147963907 cites W2144512406 @default.
• W3147963907 cites W2146082584 @default.
• W3147963907 cites W2159322366 @default.
• W3147963907 cites W2313095638 @default.
• W3147963907 cites W2314313116 @default.
• W3147963907 cites W2415954750 @default.
• W3147963907 cites W872340712 @default.
• W3147963907 hasPublicationYear "2017" @default.
• W3147963907 type Work @default.
• W3147963907 sameAs 3147963907 @default.
• W3147963907 citedByCount "1" @default.
• W3147963907 countsByYear W31479639072018 @default.
• W3147963907 crossrefType "journal-article" @default.
• W3147963907 hasAuthorship W3147963907A5011228927 @default.
• W3147963907 hasAuthorship W3147963907A5017916851 @default.
• W3147963907 hasAuthorship W3147963907A5051511541 @default.
• W3147963907 hasAuthorship W3147963907A5065636582 @default.
• W3147963907 hasAuthorship W3147963907A5066801518 @default.
• W3147963907 hasConcept C118552586 @default.
• W3147963907 hasConcept C126322002 @default.
• W3147963907 hasConcept C142724271 @default.
• W3147963907 hasConcept C15744967 @default.
• W3147963907 hasConcept C169760540 @default.
• W3147963907 hasConcept C187212893 @default.
• W3147963907 hasConcept C205778803 @default.
• W3147963907 hasConcept C2776525014 @default.
• W3147963907 hasConcept C2777630245 @default.
• W3147963907 hasConcept C2778186239 @default.
• W3147963907 hasConcept C2778261627 @default.
• W3147963907 hasConcept C2778559928 @default.
• W3147963907 hasConcept C2779134260 @default.
• W3147963907 hasConcept C2779307984 @default.
• W3147963907 hasConcept C2780673598 @default.
• W3147963907 hasConcept C551499885 @default.
• W3147963907 hasConcept C71924100 @default.
• W3147963907 hasConceptScore W3147963907C118552586 @default.
• W3147963907 hasConceptScore W3147963907C126322002 @default.
• W3147963907 hasConceptScore W3147963907C142724271 @default.
• W3147963907 hasConceptScore W3147963907C15744967 @default.
• W3147963907 hasConceptScore W3147963907C169760540 @default.
• W3147963907 hasConceptScore W3147963907C187212893 @default.
• W3147963907 hasConceptScore W3147963907C205778803 @default.
• W3147963907 hasConceptScore W3147963907C2776525014 @default.
• W3147963907 hasConceptScore W3147963907C2777630245 @default.
• W3147963907 hasConceptScore W3147963907C2778186239 @default.
• W3147963907 hasConceptScore W3147963907C2778261627 @default.
• W3147963907 hasConceptScore W3147963907C2778559928 @default.
• W3147963907 hasConceptScore W3147963907C2779134260 @default.
• W3147963907 hasConceptScore W3147963907C2779307984 @default.
• W3147963907 hasConceptScore W3147963907C2780673598 @default.
• W3147963907 hasConceptScore W3147963907C551499885 @default.
• W3147963907 hasConceptScore W3147963907C71924100 @default.
• W3147963907 hasLocation W31479639071 @default.
• W3147963907 hasOpenAccess W3147963907 @default.
• W3147963907 hasPrimaryLocation W31479639071 @default.
• W3147963907 hasRelatedWork W1598471324 @default.
• W3147963907 hasRelatedWork W1979081257 @default.
• W3147963907 hasRelatedWork W1992206607 @default.
• W3147963907 hasRelatedWork W2033671805 @default.
• W3147963907 hasRelatedWork W2076781430 @default.
• W3147963907 hasRelatedWork W2132504669 @default.
• W3147963907 hasRelatedWork W2159322366 @default.
• W3147963907 hasRelatedWork W2183086619 @default.
• W3147963907 hasRelatedWork W2327932656 @default.
• W3147963907 hasRelatedWork W2332975030 @default.
• W3147963907 hasRelatedWork W2414150801 @default.
• W3147963907 hasRelatedWork W2430193605 @default.
• W3147963907 hasRelatedWork W2463699207 @default.
• W3147963907 hasRelatedWork W2523532589 @default.

• next